Articles Archives - Page 178 of 714

FridayFeb 24, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) and Its Collaborators Are Positioned to Rapidly Develop COVID-19 Treatments to Neutralize Emerging Variants

BiondVax is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company primarily targets infectious diseases and autoimmune diseases, with its lead candidate, an inhaled COVID-19 NanoAb therapy, the subject of preclinical studies So far, the preclinical studies have shown that the NanoAb results in significantly milder illness and faster recovery, eliminates the SARS-CoV-2 virus from the lungs, and prevents illness when administered prophylactically The FDA has revoked the authorization of multiple mAb treatments and one mAb prophylactic drug, creating a significant gap in a market that has shown strong demand for COVID-19 treatments BiondVax is…

FridayFeb 24, 2023 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Highlights Commercial Customer Engagements and Cross-Platform Product Enhancements During Qubits 2023 Convention

D-Wave’s Qubits annual user conference, currently in its seventh year, is one of the industry’s premier quantum computing events differentiated by its focus on real-world applications of quantum technology The company displayed its continued commercial customer momentum and real-time product innovation, reflecting the increasing enterprise adoption of quantum computing solutions The conference demonstrated how D-Wave’s proprietary technology helps organizations solve highly complex business problems today D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced new and renewed commercial customer engagements and product updates for its annealing…

ThursdayFeb 23, 2023 12:00 pm

DX3 Canada – The Retail, Marketing And Technology Summit of 2023

DX3 is a leading event management enterprise, organizing summits and trade shows that unite retail, marketing, and technology professionals, leaders, and businesses, on a single floor. They strive to bring meaningful and informative content under one roof, offering a learning and networking opportunity to these industries for better expansion and growth. The experts offer industry insights and gather innovation solutions from international speakers as they conduct discussions, workshops, and meetings at the DX3 Canada 2023 Summit. Be a part of the panel discussions, witness tech demonstrations, and participate virtually in hybrid exhibitions to learn the most advanced and sophisticated skills…

ThursdayFeb 23, 2023 11:15 am

SideChannel Inc. (SDCH) Reports 48% Year-over-Year Revenue Growth in Q1 2023 Amid Continued Progress in Building vCISO Relationships with Clients and an Increase in Products and Services

SideChannel recently released its financial results for Q1 2023, recognizing $1,546,000 in revenue, a 48% year-over-year increase The company also ended the fiscal quarter with $2,553,000 in cash, having spent about $480,000 to offset R&D and marketing expenses SideChannel is in the business of providing cybersecurity leadership and program development through its team of virtual Chief Information Security Officers (“vCISOs”) The company has also developed Enclave, a micro-segmentation software that recently received FIPS 140 certification, opening the door for SideChannel to pursue federal and state contracts and further increase cybersecurity revenue SideChannel (OTCQB: SDCH), a company focused on delivering cybersecurity…

ThursdayFeb 23, 2023 10:30 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) CEO Joins Investor Webinar, Details Corporate Expansion Plans

EverGen Infrastructure CEO, Chase Edgelow recently joined a webinar hosted by Adelaide Capital to provide investors and stakeholders with an update on the company’s operations Edgelow elaborated on the company’s portfolio, including its 4 existing revenue generating assets, 2 projects currently under construction as well as its Ontario-based Greenfield project, Project Radius By 2Q 2023, EverGen anticipated that the completion of its RNG projects would drive gross generating capacity to 240,000 GJ/annum, whilst growing EBITDA by $5-7m per year In the longer term, successful execution on EverGen’s Ontario-based Greenfield project could see the company expand its RNG production by as…

ThursdayFeb 23, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking Forward to 2023 Goals for Patented DehydraTECH(TM) Technology

Lexaria’s 2022 R&D efforts saw high levels of success, establishing the company as one of the world’s leaders in the investigation of CBD for controlling human blood pressure and, separately, demonstrating performance enhancements compared to one of the world's leading anti-seizure medications During Q1 2023, Lexaria expects to provide additional results from its hypertension study HYPER-H21-4; complete dosing in the company’s animal dementia and diabetes studies; complete dosing in the human nicotine study NIC-H21-1; and submit and publish additional results in research journals Lexaria’s DehydraTECH technology currently has 28 granted patents, with many more pending patents in countries worldwide Lexaria…

ThursdayFeb 23, 2023 9:00 am

USMCA Developed to Bolster North American Export Services, with Freight Technologies Inc. (NASDAQ: FRGT) to Capitalize on It

Export services under NAFTA, mainly covering transportation, travel, business, and financial services, increased from $14.7 billion in 1999 to $30.4 billion in 2021 With the transition from NAFTA to USMCA, trade in goods and services is set to see a spike from 2022 going forward, and Fr8Tech expects to capitalize on this Freight Technologies Inc., with its superior freight platform for North American cross-border shipping, yielded a 45% YOY revenue growth for Q2 2022, which it looks to surpass in the subsequent quarters of the current financial year With trucks moving about 70% of North American surface trade by value,…

WednesdayFeb 22, 2023 11:15 am

Alternative Products Expo Announces Its Upcoming Fort Lauderdale 2023 Show

Alternative Products Expo has just announced its next show, which will take place on March 3-5, 2023, in the beautiful city of Fort Lauderdale, Florida. This one-of-a-kind trade show promises to provide attendees with a unique experience that breaks away from the monotony of traditional events. It's a must-attend for anyone in the smoke shop and counterculture industry. Known for short as Alt Pro Expo, this event has its roots in the Vape and CBD world and has since expanded to include a plethora of industries. With over 200 exhibitors representing various product categories, such as Vape, CBD, Hemp, Delta-8,…

WednesdayFeb 22, 2023 10:30 am

The 3rd Annual Mining Journal Select Event: Exceptional Investment Opportunities Selected By Mining Journal

Institutional and professional investors as well as mining experts, businesses, and professionals are invited to attend the Mining Journal Select Show on March 27-28th, 2023. An exclusive lineup of presenters will pitch their businesses in front of industry leaders and investors and get an opportunity for one-on-one meetings and personalized discussions with these eminent investment groups.These mining companies presenting at Mining Journal Select are selected by the Mining Journal Research & Intelligence Team, who conduct research and analysis to shortlist a curated list of companies with exceptional potential and prospects. Investors looking for robust investment avenues can leverage this forum…

WednesdayFeb 22, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders

SILO issued US Patent by USPTO titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females” Claims allowed by patent protect use of SPC-15 for treating stress-induced affective disorders, including anxiety and PTSD Other therapeutics in company pipeline include SPU-16 to treat multiple sclerosis, SPU-21 to treat rheumatoid arthritis, SPC-14 to treat Alzheimer’s disease Therapeutics developed by SILO may qualify for FDA’s streamlined 505(b)(2) regulatory drug approval pathway Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, was recently issued US Patent 11,491,120 by the US Patent and Trademark Office (“USPTO”) (https://ibn.fm/rMLOR). The…

Site Search

Company Search

Category: Articles